Method for treatment of systemic sclerosis and related fibrotic diseases
US5962025A · kind A · utility
6Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 1996 |
| Grant date | Oct 5, 1999 |
| Priority date | — |
| Expiry date | Jul 16, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/39
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a method and pharmaceutical formulations for the treatment of systemic sclerosis in mammals, by oral administration of collagen, including type I collagen, or biologically active peptide fragments thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.